Interview with P.F. Bongers, Chairman, Bogin
Having one of the highest penetration rates in Europe, generic medicines play a very important role in the Dutch pharmaceutical market. As this is the principal association for the generics…
Address: Energieweg 1, 3641 RT, Mijdrecht,Netherlands
Tel: +31 297 28 06 66
Web: http://www.bayer.nl/ebbsc/cms/nl/index.html
Bayer’s presence in the Netherlands segments Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. The main markets for Bayer products in the Netherlands are health, agriculture, construction and automotive industries. The three segments in our land will yield about 500 million euros in turnover of the parent group and employs around 600 people.
Bayer HealthCare’s aim is to human and animal health promotion. With innovative products, we are improving the welfare and quality of life by diagnosing, preventing and treating diseases.
Bayer HealthCare comprises four divisions. Bayer Shering Pharma, Animal Health, Consumer Care and Diabetes Care. There are more than 53,400 people work for Bayer HealthCare.
The business units of the division Bayer Schering Pharma – General Medicine, Specialized Therapeutics, Hematology / Oncology, Diagnostic Imaging – have medicines to treat diseases such as cancer, cardiovascular diseases, infections, immune and metabolic disorders, multiple sclerosis. There are also funds for contraception, erectile problems and products for imaging (contrast media).
Having one of the highest penetration rates in Europe, generic medicines play a very important role in the Dutch pharmaceutical market. As this is the principal association for the generics…
While already having worked for Boehringer Ingelheim for quite some time, the end of 2010 marked the completion of your first full year as general manager of this Dutch affiliate.…
Menarini is an extremely proud Italian company in its origins, but also very reliant on international markets. In 2009 approximately 63% of the group’s consolidated revenues came from abroad. What…
When it comes to the pharmaceutical and healthcare industries in the Netherlands, the country has one of the highest generic penetration rates in Europe, it does not have a strong…
WFIA is quite a remarkable organisation that has been, since its inception ten years ago, reporting very good results. The annual results last week showed another strong focus on the…
Agendia has experienced remarkable growth in the seven years since you founded the company. In 2009 you expanded the company’s Amsterdam facilities and, in 2010, you doubled the size of…
Founded in 1997 Actelion is certainly the “new kid on the block” when compared to some of the much older mainstays in the pharmaceutical industry. What would you say was…
A very strong phrase that we recently came across describes a “war going on in the generics industry” as a result of the preference policy, which people have claimed has…
Bioceros was founded as a service company built on the immunology expertise of its founders. Additional cell line expertise was added when you joined in 2007. What made this combination…
As the founder of the Institute of Young Entrepreneurs at the Delft University of Technology and an enthusiastic promoter of innovation and new technologies, what do you believe distinguishes a…
We do not often meet companies that have been successful at retaining their manufacturing facilities in the Netherlands. How and why did former Katwijk Farma -and now Apotex- succeed to…
Clearly the end of 2010 was an exciting time for you. As you entered the transition period as the new CEO of OctoPlus, you also participated in the equity raising.…
See our Cookie Privacy Policy Here
